Home > Boards > Free Zone > User's Groups > The TA Study Lounge
Followed By 7
Posts 1916
Boards Moderated 1
Alias Born 03/24/2005

Thursday, May 05, 2005 6:25:24 PM

Re: None

Post# of 18564
BIOM's Story

Biomira, Canadian Biotech company, will present updated survival rates on its lead candidate BLP25. Please remember that BLP25 has only gotten through Phase 2B trials only. Their partner is Merck Kgaa (Germany) not Merck & Co. We already know BLP25 has had impressive results on the last update given in early Dec 2004, that was the reason for the super spike you see on the charts. They will release updated survival rates, and we will know if Medium Survival Rates (MST) has been met or not. The last update indicated that MST has not been met. Which is a good thing.

Here's the Press Release Feb 22nd, 2005 Headline
American Society of Clinical Oncology (ASCO) Accepts Biomira's BLP25 Liposome Vaccine Phase IIb Non-Small Cell Lung Cancer Trial Results for Two Poster Presentations at 2005 Meeting

The meeting will take place in Orlando, Florida, May 13-17, 2005.

The ASCO Annual Meeting is the premier educational and scientific event for oncology professionals. The 2005 meeting is expected to attract more than 28,000 attendees from all over the world.

L-BLP25 is a synthetic MUC1 peptide vaccine. L-BLP25 incorporates a 25-amino acid sequence of the MUC1 cancer mucin, encapsulated in a liposomal delivery system. The liposome enhances recognition of the cancer antigen by the immune system and facilitates better delivery. L-BLP25 is designed to induce an immune response to cancer cells.

If you check up Dendreon (DNDN) they will also be presenting at ASCO had an impressive day today.

The professionals that attend ASCO have already received abstracts for the companies' presenting, look for more volatity in the Biotech sector and for possible news leak.


FEATURED A.I.S. Resources Identifies Prospective Drill Targets at Reliance Reef and Provides Bright Gold Project Update May 20, 2022 8:00 AM

Lomiko Announces Commencement of Exploration Drilling for its La Loutre Graphite Project LMR May 19, 2022 10:56 AM

PTOP Announces MOBICARD ™ 2.0 Development Contract has been executed PTOP May 19, 2022 10:00 AM

Edison Lithium Spin-Out of Cobalt Assets EDDYF May 19, 2022 8:00 AM

Goldshore Resources Announces Innovative Technology Application for Moss Lake Project Exploration and Closing of Non-Brokered Financing GSHRF May 19, 2022 8:00 AM

Demand Brands kicks off cultivation at Corralitos Farms DMAN May 18, 2022 2:00 PM

Emerging Markets Report: Details, Details SYTA May 18, 2022 11:48 AM

American Green, Inc. ™ (OTC:ERBB) Purchases 40,000sq.ft. Cannabis Grow Building for $3,750,000 ERBB May 18, 2022 9:25 AM

Green Battery Minerals Completes Resource Expansion Drilling at Zone 1 and Intersects Numerous Holes Ranging from 150 - 200 Feet of Graphite CZSVF May 18, 2022 9:19 AM

Grove Inc. Programmatic Ad Technology, Interactive Offers, Secures Milestone Patent GRVI May 18, 2022 9:11 AM

AgriFORCE Growing Systems Completes Acquisition of Food Production & Processing IP from Manna Nutritional Group (MNG) AGRI May 18, 2022 9:11 AM

HPIL Holding Secures a $CAD 32 Million Capital Commitment from GEM Global Yield LLC SCS ("GEM") HPIL May 18, 2022 9:00 AM

Branded Legacy, Inc. Increases Revenue By Expanding In New York and Florida Company Adds New Disposable Vapes BLEG May 18, 2022 8:30 AM

Demand Brands enters $8.5 million agreement with Truleaf, Inc. to enter the live rosin market DMAN May 18, 2022 8:00 AM

Emergency Response Technologies Inc, a Wholly Owned Subsidiary of ILUS International (Ilustrato Pictures International Inc), Confirms the Appointment of Law Firm Lucosky Brookman LLP to Assist with Upcoming Plans ILUS May 18, 2022 7:35 AM